Zurich Cantonal Bank’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-26,105
| Closed | -$118K | – | 2825 |
|
|
2025
Q4 | $118K | Sell |
26,105
-31,181
| -54% | -$160K | ﹤0.01% | 2362 |
|
|
2025
Q3 | $309K | Buy |
57,286
+28,033
| +96% | +$152K | ﹤0.01% | 1978 |
|
|
2025
Q2 | $159K | Buy |
29,253
+128
| +0.4% | +$508 | ﹤0.01% | 2238 |
|
|
2025
Q1 | $80.7K | Buy |
29,125
+3,648
| +14% | +$12.7K | ﹤0.01% | 2452 |
|
|
2024
Q4 | $86.9K | Hold |
25,477
| – | – | ﹤0.01% | 2472 |
|
|
2024
Q3 | $74.9K | Hold |
25,477
| – | – | ﹤0.01% | 2496 |
|
|
2024
Q2 | $86.6K | Buy |
25,477
+1
| +0% | +$3 | ﹤0.01% | 2430 |
|
|
2024
Q1 | $77.2K | Hold |
25,476
| – | – | ﹤0.01% | 2469 |
|
|
2023
Q4 | $107K | Hold |
25,476
| – | – | ﹤0.01% | 2412 |
|
|
2023
Q3 | $174K | Hold |
25,476
| – | – | ﹤0.01% | 2060 |
|
|
2023
Q2 | $265K | Buy |
25,476
+9,058
| +55% | +$81K | ﹤0.01% | 1730 |
|
|
2023
Q1 | $114K | Sell |
16,418
-1,024
| -6% | -$8.93K | ﹤0.01% | 2213 |
|
|
2022
Q4 | $105K | Buy |
17,442
+9,021
| +107% | +$66.6K | ﹤0.01% | 2237 |
|
|
2022
Q3 | $66K | Sell |
8,421
-23,171
| -73% | -$270K | ﹤0.01% | 2483 |
|
|
2022
Q2 | $430K | Buy |
31,592
+10,535
| +50% | +$174K | ﹤0.01% | 1320 |
|
|
2022
Q1 | $413K | Buy |
21,057
+4,740
| +29% | +$94.6K | ﹤0.01% | 1451 |
|
|
2021
Q4 | $560K | Buy |
16,317
+6,578
| +68% | +$265K | ﹤0.01% | 1352 |
|
|
2021
Q3 | $532K | Buy |
9,739
+5,628
| +137% | +$339K | ﹤0.01% | 1259 |
|
|
2021
Q2 | $302K | Buy |
+4,111
| New | +$411K | ﹤0.01% | 1543 |
|
Zurich Cantonal Bank's CVAC Position: Q1 2026 in Review
Zurich Cantonal Bank sold out of CureVac (CVAC) in Q1 2026, closing a stake of 26,105 shares — an estimated $118K sold.
Zurich Cantonal Bank first reported a position in CVAC in Q2 2021 and held it in 19 quarters. The position peaked at $560K in Q4 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Zurich Cantonal Bank reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Zurich Cantonal Bank sold 26,105 CureVac shares in Q1 2026, an estimated $118K.
- Zurich Cantonal Bank first reported a position in CureVac in Q2 2021 and held it in 19 quarters.
- Zurich Cantonal Bank's CureVac position peaked at $560K in Q4 2021.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.